Hypnion is a research and development firm specializing in neuroscience drug development. A subsidiary of pharmaceutical giant Eli Lilly and Company, Hypnion's particular focus is sleeping disorder research and testing. It monitors and analyzes the effects of newly developed drugs and assesses how well they treat sleeping disorders.